5-(S)-acetamidomethyl-3-[4'-(pentafluorophenyl)oxycarbonyl-3'-fluorophenyl]-oxazolidine-2-one | 232950-93-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 缩酚酸和缩酚酸环醚类
• 英文名称: 5-(S)-acetamidomethyl-3-[4'-(pentafluorophenyl)oxycarbonyl-3'-fluorophenyl]-oxazolidine-2-one
• 英文别名: 5-(S)-Acetamidomethyl-3-[4'-(pentafluorophenoxy)carbonyl-3'-fluorophenyl]-oxazolidine-2-one；5-(S)-acetamidomethyl-3-[4'-(pentafluorophenoxy)carbonyl-3'-fluorophenyl]oxazolidine-2-one；(2,3,4,5,6-pentafluorophenyl) 4-[(5S)-5-(acetamidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorobenzoate
• CAS: 232950-93-5
• 化学式: C₁₉H₁₂F₆N₂O₅
• 分子量: 462.305
• InChiKey: KZICBBSQQDUUEK-VIFPVBQESA-N

物化性质

• 沸点：
  635.0±55.0 °C(predicted)
• 密度：
  1.540±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  32
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  84.9
• 氢给体数：
  1
• 氢受体数：
  11

反应信息

• 作为反应物：
  描述：

  5-(S)-acetamidomethyl-3-[4'-(pentafluorophenyl)oxycarbonyl-3'-fluorophenyl]-oxazolidine-2-one 在 肼 作用下， 以 四氢呋喃 为溶剂， 以0.295 g (88%)的产率得到5-(S)-acetamidomethyl-3-[4'-(hydrazino)carbonyl-3'-fluorophenyl]oxazolidine-2-one
  参考文献：
  名称：

  Oxazolidinone compounds and compositions, and methods of using the same

  摘要：

  提供了噁唑烷酮及其合成方法。此外，还提供了制备生物活性噁唑烷酮的方法，以及包含噁唑烷酮的药用合成物。本文所披露的噁唑烷酮可以很容易地合成并用于各种应用，包括用作抗微生物剂。在一个实施例中，提供了各种硫代氨基甲氧噁唑烷酮及其合成和使用方法。

  公开号：

  US06441005B1
• 作为产物：
  描述：

  5-(S)-Aminomethyl-3-[4'-(tert-butoxy)carbonyl-3'-fluorophenyl]oxazolidine-2-one 在 吡啶 、 三氟乙酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 5-(S)-acetamidomethyl-3-[4'-(pentafluorophenyl)oxycarbonyl-3'-fluorophenyl]-oxazolidine-2-one
  参考文献：
  名称：

  Novel oxazolidinone–quinolone hybrid antimicrobials

  摘要：

  Antimicrobial compounds incorporating oxazolidinone and quinolone pharmacophore substructures have been synthesized and evaluated. Representative analogues 2, 5, and 6 display an improved potency versus linezolid against gram-positive and fastidious gram-negative pathogens. The compounds are also active against linezolid- and ciprofloxacin-resistant Staphylococcus aureus and Enterococcus faecium strains. The MOA for these new antimicrobials is consistent with a combination of protein synthesis and gyrase A/topoisomerase IV inhibition, with a structure-dependent degree of the contribution from each inhibitory mechanism. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.07.021

文献信息

• Oxazolidinone combinatorial libraries, compositions and methods of preparation
  申请人：Pharmacia & Upjohn Company

  公开号：US06239152B1

  公开（公告）日：2001-05-29

  Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

  提供了氧氮杂环酮及其合成方法。还提供了包含氧氮杂环酮的组合库，以及准备这些库的方法。此外，还提供了制备生物活性氧氮杂环酮的方法，以及包含氧氮杂环酮的药用合成物。制备库的方法包括将氧氮杂环酮附着到固体支持上。在一个实施例中，化合物制备的方法涉及亚磷酰胺与含有羰基的聚合物支持的反应。
• Oxazolidinone compounds and methods of preparation and use thereof
  申请人：PHARMACIA & UPJOHN COMPANY

  公开号：US20020169191A1

  公开（公告）日：2002-11-14

  Oxazolidinones and methods for their synthesis are provided. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. Oxazolidinones as disclosed herein can be readily synthesized and used in a variety of applications including use as antimicrobial agents. In one embodiment, a variety of thioamidomethyloxazolidinones and methods for their synthesis and use are provided.

  提供了氧杂环丙烷酮及其合成方法。还提供了制备生物活性氧杂环丙烷酮以及包含氧杂环丙烷酮的药学可接受组合物的方法。本文所披露的氧杂环丙烷酮可以很容易地合成并用于各种应用，包括用作抗菌剂。在一种实施例中，提供了各种硫酰胺甲基氧杂环丙烷酮及其合成和使用方法。
• Oxazalidinone compounds and methods of preparation and use thereof
  申请人：Pharmacia & Upjohn Company

  公开号：US06743811B2

  公开（公告）日：2004-06-01

  Oxazolidinones and methods for their synthesis are provided. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. Oxazolidinones as disclosed herein can be readily synthesized and used in a variety of applications including use as antimicrobial agents. In one embodiment, a variety of thioamidomethyloxazolidinones and methods for their synthesis and use are provided.

  本发明提供了噁唑烷酮及其合成方法。还提供了制备生物活性噁唑烷酮的方法，以及包含噁唑烷酮的药学可接受组合物的方法。本发明所披露的噁唑烷酮可以很容易地合成，并可用于各种应用，包括用作抗微生物剂。在一种实施例中，提供了各种硫代酰胺甲基噁唑烷酮及其合成和使用方法。
• OXAZOLIDINONE COMBINATORIAL LIBRARIES, COMPOSITIONS AND METHODS OF PREPARATION
  申请人：Versicor, Inc.

  公开号：EP1049682A1

  公开（公告）日：2000-11-08
• US6239152B1
  申请人：——

  公开号：US6239152B1

  公开（公告）日：2001-05-29